創薬サービス市場調査レポート 2030年までの予測

Drug Discovery Services Market research report Forecast to 2030

創薬サービス市場調査レポート 2030年までの予測市場の概要創薬サービス市場産業は、予測期間中に13.92%の著しいCAGRを示すと予測される。医薬品開発の再適用の進展と探査・改良費用の拡大が、創薬サービ... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Market Research Future マーケットリサーチフューチャー (MRFR)	2023年3月17日	US$7,250 ライセンス・価格情報注文方法はこちら	110	英語

目次
図表リスト

サマリー

創薬サービス市場調査レポート 2030年までの予測

市場の概要
創薬サービス市場産業は、予測期間中に13.92%の著しいCAGRを示すと予測される。医薬品開発の再適用の進展と探査・改良費用の拡大が、創薬サービス市場の発展をアップグレードする主要な市場ドライバーです。
医薬品およびバイオ医薬品企業は、研究開発費の拡大により、初期の改良段階から後期の進歩段階まで、医薬品の革新的な作業に対して完全に調整された、または実用的な再考サービスを選んでいます。製薬会社は固定費の抑制に大きな負担を強いられていますが、新薬の開発に必要な内部資産の不足を補う戦略的な答えとして、再充当が浮上しています。巨大な製薬会社は、再考を明確に強調する、より合理的な企業手法へと変化しています。
治療目的の範囲において、想像力豊かな治療薬へのニーズが拡大している。薬剤探索サービス絶え間ない病気に対する想像力豊かな治療法への要求の高まりと医療業界の進歩が、市場発展の主要な促進要因になると予想される。医薬品・バイオ医薬品企業は、革新的な研究開発活動をCROに委託しています。CROは研究開発サービスを提供し、研究開発の生産性を高めるためのコミットメントモデルを作っています。立法府と医薬品企業は、持続的な病気の拡大により、答えを探し、臨床前段階への関心を高めることを余儀なくされています。その結果、創薬サービスに対する要求がより顕著になることが予想されます。
市場区分
創薬サービス市場は、薬剤の種類に基づき、低分子医薬品、生物製剤に分類されています。タイプに基づき、薬物代謝・薬物動態（DMPK）サービス、医薬品サービス、その他に分類されています。創薬サービス市場の治療領域は、オンコロジー、その他に二分される。
地域別分析
北米は、創薬研究開発への関心が高く、研究基盤を整備した重要な企業や専門的なアップグレードを行う企業が多いことから、世界の創薬サービス市場を牽引する可能性があります。この時点で、再考は単に費用の削減だけでなく、実行可能性、品質、開発に対する要求が高まっており、業界の拡大を後押しすると予想されます。
アジア太平洋地域の創薬サービス市場は、優秀な人材の確保、安価なコスト、良好な行政環境、優れた情報により、最も高い成長が見込まれており、この地域は医薬品改良の再適用の中心地へと急速に変化しつつあります。地球上で2番目に大きな医薬品市場である日本は、CROに大きな可能性を与え、ビジネスを牽引することが期待されています。
技術革新の急速な進展と大都市圏の発展が、欧州の創薬サービス市場を後押ししています。生物製剤やバイオシミラーの改良により、バイオ製薬会社からの投機が拡大し、それが欧州の承認医薬品数の増加につながっています。欧州の創薬サービス市場は、多くの重要な組織によるさまざまな臨床および非臨床試験での消費の拡大によって牽引されると予想され、少数のCRO専門家協同組合に移され、効率的なアイテム改良に役立っている。
主要プレイヤー
Abbott Laboratories Inc.、Advinus Therapeutics、Albany Molecular Research Inc.（AMRI）、Aurigene、Agilent Technologies Ubiquigent、AstraZeneca PLC、Retrogenix（英国）、Charles River Laboratories International, Eurofins、Liverpool ChiroChem Ltd．

ページTOPに戻る

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING RESEARCH & DEVELOPMENT EXPENDITURE

4.2.2 RISING DRUG DEVELOPMENT OUTSOURCING

4.3 RESTRAINTS

4.3.1 STRINGENT REGULATORY POLICIES AND COSTS ASSOCIATED TO DRUG DISCOVERY

4.4 OPPORTUNITY

4.4.1 TECHNOLOGICAL ADVANCEMENTS IN DRUG DISCOVERY

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 CUSTOMER ACQUISITION (PREPURCHASE QUERY)

5.1.2 SERVICE CUSTOMIZATION

5.1.2.1 R&D

5.1.2.2 GOOD LABORATORY PRACTICES (GLP)

5.1.3 CUSTOMER PURCHASE SUPPORT

5.1.4 CUSTOMER FULFILMENT & POST-PURCHASE SUPPORT

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 COVID-19 IMPACT ON THE DRUG DISCOVERY SERVICES MARKET

5.3.1 IMPACT ON R&D

5.3.2 IMPACT ON PRICING

5.3.3 IMPACT ON MARKET GROWTH

6 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE

6.1 OVERVIEW

6.2 SMALL MOLECULE DRUG

6.3 BIOLOGICS DRUG

7 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES

7.1 OVERVIEW

7.2 DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES

7.3 PHARMACEUTICAL SERVICES

7.4 MEDICINAL CHEMISTRY

7.5 BIOLOGICAL SERVICES

7.6 MEDICATION

8 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA

8.1 OVERVIEW

8.2 ONCOLOGY

8.3 CARDIOVASCULAR DISEASES

8.4 RESPIRATORY DISEASES

8.5 DIABETES

8.6 OTHERS

9 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY

9.1 OVERVIEW

9.2 HIGH THROUGHPUT SCREENING

9.3 BIOCHIPS

9.4 PHARMACOGENOMICS AND PHARMACOGENETICS

9.5 METABOLOMICS

9.6 OTHERS

10 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY END USER

10.1 OVERVIEW

10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

10.3 RESEARCH & ACADEMIC INSTITUTES

10.4 OTHERS

11 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY REGION

11.1 OVERVIEW

11.2 NORTH AMERICA

11.2.1 US

11.2.2 CANADA

11.3 EUROPE

11.3.1 GERMANY

11.3.2 FRANCE

11.3.3 UK

11.3.4 ITALY

11.3.5 SPAIN

11.3.6 REST OF EUROPE

11.4 ASIA-PACIFIC

11.4.1 CHINA

11.4.2 JAPAN

11.4.3 INDIA

11.4.4 AUSTRALIA

11.4.5 SOUTH KOREA

11.4.6 REST OF ASIA-PACIFIC

11.5 REST OF THE WORLD

11.5.1 MIDDLE EAST

11.5.2 AFRICA

11.5.3 LATIN AMERICA

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW

12.2 COMPETITIVE BENCHMARKING

12.3 MAJOR GROWTH STRATEGY IN DRUG DISCOVERY SERVICES MARKET

12.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN DRUG DISCOVERY SERVICES MARKET

12.5 KEY DEVELOPMENTS & GROWTH STRATEGIES

12.5.1 SERVICE LAUNCH

12.5.2 MERGERS & ACQUISITIONS

12.5.3 PARTNERSHIP/COLLABORATION

12.6 MAJOR PLAYERS SALES ANALYSIS

12.6.1 SALES & OPERATING INCOME, 2021 (USD MILLION)

12.6.2 MAJOR PLAYERS R&D ANALYSIS, 2021 (USD MILLION)

13 COMPANY PROFILE

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 COMPANY OVERVIEW

13.1.2 FINANCIAL OVERVIEW

13.1.3 SERVICES OFFERED

13.1.4 KEY DEVELOPMENTS

13.1.5 SWOT ANALYSIS

13.1.6 KEY STRATEGIES

13.2 ARAGEN LIFE SCIENCES PVT. LTD.

13.2.1 COMPANY OVERVIEW

13.2.2 FINANCIAL OVERVIEW

13.2.3 SERVICES OFFERED

13.2.4 KEY DEVELOPMENTS

13.2.5 KEY STRATEGIES

13.3 PIRAMAL PHARMA SOLUTIONS

13.3.1 COMPANY OVERVIEW

13.3.2 FINANCIAL OVERVIEW

13.3.3 SERVICES OFFERED

13.3.4 KEY DEVELOPMENTS

13.3.5 KEY STRATEGIES

13.4 CURIA GLOBAL, INC.

13.4.1 COMPANY OVERVIEW

13.4.2 FINANCIAL OVERVIEW

13.4.3 SERVICES OFFERED

13.4.4 KEY STRATEGIES

13.5 CHARLES RIVER LABORATORIES

13.5.1 COMPANY OVERVIEW

13.5.2 FINANCIAL OVERVIEW

13.5.3 SERVICES OFFERED

13.5.4 KEY DEVELOPMENTS

13.5.5 SWOT ANALYSIS

13.5.6 KEY STRATEGIES

13.6 EUROFINS SCIENTIFIC

13.6.1 COMPANY OVERVIEW

13.6.2 FINANCIAL OVERVIEW

13.6.3 SERVICES OFFERED

13.6.4 KEY DEVELOPMENTS

13.6.5 SWOT ANALYSIS

13.6.6 KEY STRATEGIES

13.7 IQVIA

13.7.1 COMPANY OVERVIEW

13.7.2 FINANCIAL OVERVIEW

13.7.3 SERVICES OFFERED

13.7.4 KEY DEVELOPMENTS

13.7.5 SWOT ANALYSIS

13.7.6 KEY STRATEGIES

13.8 EVOTEC

13.8.1 COMPANY OVERVIEWS

13.8.2 FINANCIAL OVERVIEW

13.8.3 SERVICES OFFERED

13.8.4 KEY DEVELOPMENTS

13.8.5 KEY STRATEGIES

13.9 WUXI APPTEC CO., LTD.

13.9.1 COMPANY OVERVIEW

13.9.2 FINANCIAL OVERVIEW

13.9.3 SERVICES OFFERED

13.9.4 KEY DEVELOPMENTS

13.9.5 SWOT ANALYSIS

13.9.6 KEY STRATEGIES

13.10 LABORATORY CORPORATION OF AMERICA HOLDINGS

13.10.1 COMPANY OVERVIEW

13.10.1 FINANCIAL OVERVIEW

13.10.2 SERVICES OFFERED

13.10.3 KEY DEVELOPMENTS

13.10.4 KEY STRATEGIES

13.11 SELVITA

13.11.1 COMPANY OVERVIEW

13.11.2 FINANCIAL OVERVIEW

13.11.3 SERVICES OFFERED

13.11.4 KEY DEVELOPMENTS

13.11.5 SWOT ANALYSIS

13.11.6 KEY STRATEGIES

13.12 SYGNATURE DISCOVERY

13.12.1 COMPANY OVERVIEW

13.12.2 FINANCIAL OVERVIEW

13.12.3 SERVICES OFFERED

13.12.4 KEY DEVELOPMENTS

13.12.5 SWOT ANALYSIS

13.12.6 KEY STRATEGIES

13.13 SYMERES

13.13.1 COMPANY OVERVIEW

13.13.2 FINANCIAL OVERVIEW

13.13.3 SERVICES OFFERED

13.13.4 KEY DEVELOPMENTS

13.13.5 SWOT ANALYSIS

13.13.6 KEY STRATEGIES

13.14 NUCHEM SCIENCES INC.

13.14.1 COMPANY OVERVIEW

13.14.2 FINANCIAL OVERVIEW

13.14.3 SERVICES OFFERED

13.14.4 KEY STRATEGIES

13.15 PARAZA PHARMA, INC.

13.15.1 COMPANY OVERVIEW

13.15.2 FINANCIAL OVERVIEW

13.15.3 SERVICES OFFERED

13.15.4 KEY DEVELOPMENTS

13.15.5 KEY STRATEGIES

14 APPENDIX

14.1 REFERENCES

14.2 RELATED REPORTS

ページTOPに戻る

図表リスト

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 4 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR SMALL MOLECULE DRUG, BY REGION, 2023-2030 (USD MILLION)

TABLE 5 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR BIOLOGICS DRUG, BY REGION, 2023-2030 (USD MILLION)

TABLE 6 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2023-2030 (USD MILLION)

TABLE 7 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, BY REGION, 2023-2030 (USD MILLION)

TABLE 8 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR PHARMACEUTICAL SERVICES, BY REGION, 2023-2030 (USD MILLION)

TABLE 9 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR MEDICINAL CHEMISTRY, BY REGION, 2023-2030 (USD MILLION)

TABLE 10 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR BIOLOGICAL SERVICES, BY ERGION, 2023-2030 (USD MILLION)

TABLE 11 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR MEDICATION, BY REGION, 2023-2030 (USD MILLION)

TABLE 12 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 13 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR ONCOLOGY, BY REGION, 2023-2030 (USD MILLION)

TABLE 14 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR CARDIOVASCULAR DISEASES, BY REGION, 2023-2030 (USD MILLION)

TABLE 15 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR RESPIRATORY DISEASES, BY REGION, 2023-2030 (USD MILLION)

TABLE 16 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR DIABETES, BY REGION, 2023-2030 (USD MILLION)

TABLE 17 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR OTHERS, BY REGION, 2023-2030 (USD MILLION)

TABLE 18 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 19 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR HIGH THROUGHPUT SCREENING COMPANIES, BY REGION, 2023-2030 (USD MILLION)

TABLE 20 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR BIOCHIPS, BY REGION, 2023-2030 (USD MILLION)

TABLE 21 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR PHARMACOGENOMICS AND PHARMACOGENETICS, BY REGION, 2023-2030 (USD MILLION)

TABLE 22 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR METABOLOMICS, BY REGION, 2023-2030 (USD MILLION)

TABLE 23 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR OTHERS, BY REGION, 2023-2030 (USD MILLION)

TABLE 24 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR END USER, BY REGION, 2023-2030 (USD MILLION)

TABLE 25 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)

TABLE 26 LOBAL DRUG DISCOVERY SERVICES MARKET, FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2023-2030 (USD MILLION)

TABLE 27 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR OTHERS, BY REGION, 2023-2030 (USD MILLION)

TABLE 28 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)

TABLE 29 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)

TABLE 30 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 31 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2023-2030 (USD MILLION)

TABLE 32 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 33 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 34 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 35 US: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 36 US: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)

TABLE 37 US: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 38 US: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 39 US: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 40 CANADA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 41 CANADA: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)

TABLE 42 CANADA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 43 CANADA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 44 CANADA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 45 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)

TABLE 46 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 47 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)

TABLE 48 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 49 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 50 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 51 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 52 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)

TABLE 53 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 54 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 55 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 56 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 57 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)

TABLE 58 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 59 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 60 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 61 UK: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 62 UK: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)

TABLE 63 UK: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 64 UK: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 65 UK: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 66 ITALY: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 67 ITALY: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)

TABLE 68 ITALY: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 69 ITALY: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 70 ITALY: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 71 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 72 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)

TABLE 73 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 74 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 75 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 76 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 77 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)

TABLE 78 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 79 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 80 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 81 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)

TABLE 82 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 83 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 84 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 85 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 86 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 87 CHINA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 88 CHINA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 89 CHINA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 90 CHINA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 91 CHINA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 92 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 93 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 94 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 95 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 96 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 97 INDIA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 98 INDIA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 99 INDIA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 100 INDIA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 101 INDIA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 102 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 103 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 104 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 105 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 106 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 107 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 108 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 109 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 110 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 111 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 112 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 113 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 114 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 115 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 116 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 117 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)

TABLE 118 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 119 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 120 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 121 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 122 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 123 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 124 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 125 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 126 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 127 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 128 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 129 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 130 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 131 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 132 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 133 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)

TABLE 134 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)

TABLE 135 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)

TABLE 136 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)

TABLE 137 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 138 MAJOR MANUFACTURERS IN DRUG DISCOVERY SERVICES MARKET

TABLE 139 MOST ACTIVE PLAYER IN DRUG DISCOVERY SERVICES MARKET

TABLE 140 SERVICE LAUNCH

TABLE 141 MERGERS & ACQUISITIONS

TABLE 142 PARTNERSHIP/COLLABORATION

TABLE 143 THERMO FISHER SCIENTIFIC INC.: SERVICES OFFERED

TABLE 144 ARAGEN LIFE SCIENCES PVT. LTD.: SERVICES OFFERED

TABLE 145 ARAGEN LIFE SCIENCES PVT.: KEY DEVELOPMENTS

TABLE 146 PIRAMAL PHARMA SOLUTIONS: SERVICES OFFERED

TABLE 147 CURIA GLOBAL, INC.: SERVICES OFFERED

TABLE 148 CURIA GLOBAL, INC.: KEY DEVELOPMENTS

TABLE 149 CHARLES RIVER LABORATORIES: SERVICES OFFERED

TABLE 150 CHARLES RIVER LABORATORIES: KEY DEVELOPMENTS

TABLE 151 EUROFINS SCIENTIFIC: SERVICES OFFERED

TABLE 152 EUROFINS SCIENTIFIC: KEY DEVELOPMENTS

TABLE 153 IQVIA: SERVICES OFFERED

TABLE 154 EVOTEC: SERVICES OFFERED

TABLE 155 EVOTEC: KEY DEVELOPMENTS

TABLE 156 WUXI APPTEC CO., LTD.: SERVICES OFFERED

TABLE 157 WUXI APPTEC CO., LTD.: KEY DEVELOPMENTS

TABLE 158 LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICES OFFERED

TABLE 159 SELVITA: SERVICES OFFERED

TABLE 160 SELVITA: KEY DEVELOPMENTS

TABLE 161 SYGNATURE DISCOVERY: SERVICES OFFERED

TABLE 162 SYGNATURE DISCOVERY: KEY DEVELOPMENTS

TABLE 163 SYMERES: SERVICES OFFERED

TABLE 164 SYMERES: KEY DEVELOPMENTS

TABLE 165 NUCHEM SCIENCES INC.: SERVICES OFFERED

TABLE 166 NUCHEM SCIENCES INC.: KEY DEVELOPMENTS

TABLE 167 PARAZA PHARMA, INC.: SERVICES OFFERED

ページTOPに戻る

Table of Contents
List of Tables/Graphs

Summary

Drug Discovery Services Market research report Forecast to 2030

Market Overview
The Drug Discovery Services market industry is projected to exhibit a significant CAGR of 13.92% during the forecast period. Developing Re-appropriating of Drug Advancement and Expanding Exploration and Improvement Expenses are the key market drivers upgrading the Drug Discovery Services market development.
Drug and biopharmaceutical organizations are picking completely coordinated or practical rethinking services for drug innovative work from the early improvement stage to the late-stage advancement stage due to expanded Research and development consumptions. While drug organizations are under extraordinary strain to monitor fixed costs, re-appropriating has arisen as a strategic answer for the absence of inside assets required for new item improvement. Enormous pharma firms are changing to a more streamlined corporate methodology that unequivocally stresses rethinking.
Expanding need for imaginative therapeutics across a scope of restorative objectives. Drug-finding services Rising requirement for imaginative therapies for constant sicknesses and headways in the medical care industry are anticipated to be the primary drivers of market development. Drug and biopharmaceutical organizations actually contract their innovative work (Research and Development) activities to CROs, who offer Research and development services and make commitment models to boost Research and development productivity. Legislatures and drug enterprises are compelled to search for answers and lift their interest in clinical preliminaries because of the expanded weight of persistent sicknesses. Subsequently, there will be a more prominent requirement for drug discovery services.
Market Segmentation
Based on Drug Type, the Drug Discovery Services market has been classified into Small Molecule Drugs, Biologics’ Based on type, the market is divided into Drug metabolism and pharmacokinetics (DMPK) Services, Pharmaceutical Services, and Others. Therapeutic Areas of the Drug Discovery Services market are bifurcated into data into Oncology, Others.
Regional Analysis
North America is likely to drive the global Drug Discovery Services market due to the higher interest in drug discovery Research and development, critical firms with laid-out research foundations, and specialized upgrades. As rethinking is at this point not just about reducing expenses, a developing requirement for viability, quality, and development is expected to help industry extension.
The Asia Pacific drug discovery services market is anticipated to develop the highest growth owing to the accessibility of qualified individuals, less expensive costs, a successful administrative climate, and great information, the Region is rapidly turning into a center for re-appropriating drug improvement exercises. The second-biggest drug market on the planet, Japan, is expected to furnish CROs with a sizable potential, driving the business.
The fast improvement of innovation and the development of metropolitan regions impel the European drug discovery services market. The improvement of biologics and biosimilars has seen an expansion in speculation from biopharmaceutical firms, which is liable for the ascent in the number of approved drugs in Europe. The European drug discovery services market is expected to be driven by expanding consumptions made by many significant organizations in different clinical and non-clinical examination exercises that are moved to a few CRO specialist co-ops and help with proficient item improvement.
Major Players
Abbott Laboratories Inc., Advinus Therapeutics, Albany Molecular Research Inc. (AMRI), Aurigene, Agilent Technologies Ubiquigent, AstraZeneca PLC, Retrogenix (U.K.), Charles River Laboratories International, Eurofins, and Liverpool ChiroChem Ltd.

ページTOPに戻る

List of Tables/Graphs

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医薬）の最新刊レポート

Market Research Future社の医薬品分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

Market Research Future社はどのような調査会社ですか?

マーケットリサーチフューチャー（Market Research Future）は世界市場を幅広く調査し、主要分野、地域、国レベルの調査レポートを出版しています。下記分野については、分野毎に専... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

創薬サービス市場調査レポート 2030年までの予測

サマリー

目次

図表リスト

Summary

Table of Contents

List of Tables/Graphs

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医薬）の最新刊レポート

Market Research Future社の医薬品分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

Market Research Future社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?